Medicare and Medicaid
Our work in Medicare and Medicaid
-
Revising Payment to Medicare Advantage Plans to Reflect the Rapid Growth in Enrollment
Medicare Advantage enrollment is projected to represent the majority of Medicare beneficiaries enrolled in both Part A and Part B by 2023. This event will discuss this trend and the financial implications.
-
Comments On the 2023 Advance Notice On Medicare Part C and D Payment Policies
Matthew Fiedler and Richard Frank commented on the 2023 Medicare Part C and D Advance Notice issued by the Centers for Medicare and Medicaid Services (CMS).
Categorized in -
The Debate on Overpayment In Medicare Advantage: Pulling It together
Health Affairs Forefront has published articles that advance two diametrically opposing assessments of issues regarding the Medicare Advantage program. Ginsburg and Lieberman discuss them and why it is important to come to agreement.
Categorized in -
From Vision to Design in Advancing Medicare Payment Reform: A Blueprint for Population-Based Payments
With Medicare spending growth over the next decade expected to exceed GDP growth, the trust fund projected to be depleted in 2026, and evidence of persistent and pervasive waste and disparities in health care, attention has returned to the role of payment reform in controlling Medicare spending growth and driving more efficient and equitable care delivery.
Categorized in -
Money for the Infrastructure Bill is Coming at the Expense of Medicare Part D
The $1 trillion infrastructure bill will leave a lot of chronically ill people by the side of the road.Â
Categorized in -
Options for Containing the Cost of a New Medicare Dental, Hearing, and Vision Benefit
USC-Brookings Schaeffer Initiative for Health Policy expert Matthew Fiedler analyzes options for reducing the cost of adding dental, hearing and vision coverage to Medicare.
Categorized in -
Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis
Policy makers have suggested increasing peritoneal dialysis (PD) would improve end-stage kidney disease (ESKD) outcomes and reduce Medicare spending compared with hemodialysis (HD). We compared mortality, hospitalizations, and Medicare spending between PD and HD among uninsured adults with incident ESKD.
Categorized in -
Do Medicare’s Facility Fees Incentivize Hospitals to Vertically Integrate with Oncologists?
A new paper examining whether or not hospitals strategically choose to vertically integrate with clinical oncologists in order to capture facility fees, a commonly cited reason for increased consolidation in the healthcare market.
Categorized in -
Comparison of Spending on Common Generic Drugs by Medicare vs Costco Members
A new Schaeffer Center study comparing Medicare Part D prescription drug prices with those paid by Costco members finds that the federal government overpaid on roughly half of the most common generic medicines in 2018.
Categorized in -
USC Research Shows Costco Beats Medicare in Generic Drug Savings Nearly 50% of the Time
Intermediaries negotiate good prices, but lack incentives to pass savings to beneficiaries and taxpayers.
Categorized in